持田製薬の株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2023/12/13 | 3,295 | 3,325 | 3,280 | 3,300 | +5 | +0.2% | 16,900 |
| 2023/12/12 | 3,330 | 3,340 | 3,290 | 3,295 | -5 | -0.2% | 14,900 |
| 2023/12/11 | 3,280 | 3,315 | 3,280 | 3,300 | +30 | +0.9% | 25,600 |
| 2023/12/08 | 3,315 | 3,330 | 3,250 | 3,270 | -80 | -2.4% | 43,900 |
| 2023/12/07 | 3,390 | 3,395 | 3,345 | 3,350 | -60 | -1.8% | 24,400 |
| 2023/12/06 | 3,380 | 3,425 | 3,365 | 3,410 | +60 | +1.8% | 69,000 |
| 2023/12/05 | 3,345 | 3,380 | 3,345 | 3,350 | -15 | -0.4% | 29,500 |
| 2023/12/04 | 3,365 | 3,375 | 3,330 | 3,365 | ±0 | ±0% | 28,900 |
| 2023/12/01 | 3,400 | 3,425 | 3,355 | 3,365 | +10 | +0.3% | 54,800 |
| 2023/11/30 | 3,315 | 3,355 | 3,255 | 3,355 | -25 | -0.7% | 136,200 |
| 2023/11/29 | 3,385 | 3,395 | 3,365 | 3,380 | -10 | -0.3% | 31,600 |
| 2023/11/28 | 3,350 | 3,395 | 3,345 | 3,390 | +55 | +1.6% | 33,800 |
| 2023/11/27 | 3,340 | 3,345 | 3,315 | 3,335 | +30 | +0.9% | 27,100 |
| 2023/11/24 | 3,285 | 3,310 | 3,270 | 3,305 | +10 | +0.3% | 23,200 |
| 2023/11/22 | 3,245 | 3,300 | 3,245 | 3,295 | +60 | +1.9% | 32,300 |
| 2023/11/21 | 3,195 | 3,240 | 3,195 | 3,235 | +40 | +1.3% | 25,800 |
| 2023/11/20 | 3,235 | 3,245 | 3,180 | 3,195 | -40 | -1.2% | 30,100 |
| 2023/11/17 | 3,200 | 3,240 | 3,200 | 3,235 | +45 | +1.4% | 28,400 |
| 2023/11/16 | 3,225 | 3,260 | 3,180 | 3,190 | -75 | -2.3% | 43,200 |
| 2023/11/15 | 3,295 | 3,300 | 3,230 | 3,265 | -20 | -0.6% | 54,600 |
| 2023/11/14 | 3,310 | 3,310 | 3,285 | 3,285 | ±0 | ±0% | 23,200 |
| 2023/11/13 | 3,310 | 3,315 | 3,285 | 3,285 | -25 | -0.8% | 15,800 |
| 2023/11/10 | 3,270 | 3,315 | 3,265 | 3,310 | +5 | +0.2% | 21,200 |
| 2023/11/09 | 3,370 | 3,370 | 3,270 | 3,305 | -15 | -0.5% | 20,300 |
| 2023/11/08 | 3,300 | 3,330 | 3,280 | 3,320 | +20 | +0.6% | 26,700 |
| 2023/11/07 | 3,335 | 3,360 | 3,295 | 3,300 | -50 | -1.5% | 32,100 |
| 2023/11/06 | 3,395 | 3,400 | 3,310 | 3,350 | +25 | +0.8% | 49,300 |
| 2023/11/02 | 3,320 | 3,380 | 3,310 | 3,325 | -65 | -1.9% | 28,500 |
| 2023/11/01 | 3,380 | 3,395 | 3,360 | 3,390 | +80 | +2.4% | 45,100 |
| 2023/10/31 | 3,225 | 3,320 | 3,225 | 3,310 | +105 | +3.3% | 41,100 |
| 2023/10/30 | 3,260 | 3,290 | 3,190 | 3,205 | -120 | -3.6% | 42,100 |
| 2023/10/27 | 3,275 | 3,325 | 3,255 | 3,325 | +70 | +2.2% | 29,500 |
| 2023/10/26 | 3,280 | 3,320 | 3,240 | 3,255 | -45 | -1.4% | 37,000 |
| 2023/10/25 | 3,310 | 3,330 | 3,300 | 3,300 | -10 | -0.3% | 17,600 |
| 2023/10/24 | 3,310 | 3,325 | 3,245 | 3,310 | -15 | -0.5% | 21,200 |
| 2023/10/23 | 3,295 | 3,350 | 3,295 | 3,325 | +15 | +0.5% | 27,000 |
| 2023/10/20 | 3,280 | 3,330 | 3,280 | 3,310 | +20 | +0.6% | 19,400 |
| 2023/10/19 | 3,230 | 3,305 | 3,230 | 3,290 | +30 | +0.9% | 23,800 |
| 2023/10/18 | 3,295 | 3,295 | 3,215 | 3,260 | +15 | +0.5% | 24,300 |
| 2023/10/17 | 3,240 | 3,270 | 3,215 | 3,245 | +5 | +0.2% | 25,300 |
| 2023/10/16 | 3,215 | 3,275 | 3,210 | 3,240 | -30 | -0.9% | 27,800 |
| 2023/10/13 | 3,320 | 3,320 | 3,270 | 3,270 | -70 | -2.1% | 16,900 |
| 2023/10/12 | 3,365 | 3,365 | 3,315 | 3,340 | -5 | -0.1% | 12,800 |
| 2023/10/11 | 3,375 | 3,375 | 3,330 | 3,345 | -10 | -0.3% | 24,900 |
| 2023/10/10 | 3,350 | 3,370 | 3,330 | 3,355 | +35 | +1.1% | 26,700 |
| 2023/10/06 | 3,270 | 3,340 | 3,270 | 3,320 | +40 | +1.2% | 21,900 |
| 2023/10/05 | 3,205 | 3,285 | 3,205 | 3,280 | +75 | +2.3% | 32,600 |
| 2023/10/04 | 3,200 | 3,235 | 3,175 | 3,205 | -5 | -0.2% | 25,800 |
| 2023/10/03 | 3,285 | 3,290 | 3,210 | 3,210 | -75 | -2.3% | 31,900 |
| 2023/10/02 | 3,370 | 3,370 | 3,285 | 3,285 | -50 | -1.5% | 33,200 |
351～
400
件表示中 / 3705件
類似銘柄と比較する
現在ご覧いただいている「持田薬」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| 持田薬 | 297,600円 | +5.1% | -7.0% | 2.69% | 19.54倍 | 0.81倍 |
|
医薬中堅。高脂血症薬、降圧薬など循環器系得意。婦人科系にも強み。消化器系育成。化粧品も |
| ジーエヌアイ | 297,100円 | +21.7% | +999.9% | 0.00% | 12.45倍 | 4.12倍 |
|
中国の特発性肺線維症で高シェア、肺線維症後続薬進出。米国で人工骨も。米中に研究開発機能 |
| ゼリア新薬 | 213,700円 | +3.1% | -6.5% | 2.25% | 9.92倍 | 1.05倍 |
|
製薬中堅。医療用は消化器系中心。滋養強壮剤「ヘパリーゼ」も柱。スイス企業買収で海外展開 |
| 杏林製薬 | 146,000円 | -2.4% | -52.3% | 3.90% | 17.47倍 | 0.62倍 |
|
医薬中堅。柱のぜんそく薬、呼吸器アレルギー薬は下期に比重。消化器領域育成。後発品も |
| 栄研化 | 200,000円 | +4.1% | -3.1% | 2.90% | 17.54倍 | 1.53倍 |
|
臨床検査薬大手。便潜血検査試薬（ＦＩＴ）はシェア７割。尿検査（ウロ）、遺伝子検査も育成 |
市場注目の銘柄
チャート関連のコラム
